Geltor's proprietary fermentation-based platform enables the production of biomimetic human proteins like collagen and elastin without the use of any human or animal inputs, reliably and at scale. HumaColl21® and Elastapure® make up two of the Elements of Skin™, available only through Geltor
Functional bioactive ingredients made possible by recent breakthroughs in biological manufacturing are taking the beauty and personal care industry by storm.
Driven by consumers’ demands for sustainable, ethically sourced, and effective ingredients, Geltor is the leader in innovative biodesigned proteins for beauty and personal care.
The California-based company is making otherwise impossible-to-source actives which biologically match human collagen and elastin available for the first time to brands looking to future-proof with highly effective hero ingredients that are sustainable and animal-free.
HumaColl21® revolutionised the industry as the first ever biomimetic human collagen for beauty and personal care. Elastapure® is Geltor’s newest protein, and the first human biomimetic human elastin for topical use.
A major component of human skin, elastin functions alongside collagen in the body and provides elasticity through its moisture-retaining properties and unique ability as a protein to stretch and recoil. Similarly to collagen and other building blocks of skin, production of elastin in the body visibly decreases over time.
Historically, consumers looking to counteract the natural decline of these proteins have had to depend on animal sources.
Geltor’s proprietary fermentation-based biodesign platform enables the production of biomimetic human proteins like collagen and elastin without the use of any human or animal inputs, reliably and at scale.
Together, HumaColl21® and Elastapure® make up two of the Elements of Skin™, available only through Geltor.
Both ingredients are Halal, non-GMO, and vegan and cruelty-free certified, ideal for green and clean beauty formulations. For additional information, and extensive details on clinical efficacy studies, contact Geltor at email@example.com